FSTX NASDAQ
F-star Therapeutics, Inc.
1W: +27.1%
1M: +49.0%
3M: +28.3%
1Y: +143.0%
$7.12
Last traded 2023-03-08 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$21M
Revenue
+2719.6% YoY
$-45M
Net Income
-70.2% YoY
$-38M
Free Cash Flow
-90.3% YoY
100.0%
Gross Margin
-1218.3%
Op. Margin
-1641.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-61.2%
ROA-45.3%
ROIC-85.6%
Valuation
P/E-3.8
P/B1.2
EV/EBITDA-2.0
Leverage
Debt/Equity0.22
Current Ratio3.38
Interest Cov.-257.2x
Quality Scores
Piotroski F2/9
Altman Z-0.66
Beneish M-0.74